Powerful flow cytometry tech accelerates stem cell research
Learn about the pioneering work of the Columbia Stem Cell Initiative and how tech is helping drive scientific breakthroughs at its Flow Cytometry Core Facility
Stay updated with breaking news from Stem Cell Core Facility. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Learn about the pioneering work of the Columbia Stem Cell Initiative and how tech is helping drive scientific breakthroughs at its Flow Cytometry Core Facility
Learn about the pioneering work of the Columbia Stem Cell Initiative and how tech is helping drive scientific breakthroughs at its Flow Cytometry Core Facility
French Minister of Higher Education, Research and Innovation Frédérique Vidal, PhD, visited the Columbia Stem Cell Initiative (CSCI) on Saturday, Dec
Press release content from Business Wire. The AP news staff was not involved in its creation. Axion BioSystems Announces Formation of Scientific Advisory Board April 20, 2021 GMT ATLANTA--(BUSINESS WIRE)--Apr 20, 2021-- Axion BioSystems, a leading life science tools company focused on developing and commercializing label-free, bioelectronic assays used to study the function of live cells in vitro, announces the formation of a Scientific Advisory Board (SAB). The SAB will be chaired by Jim Ross, Ph.D., founder and Chief Technology Officer, and will work closely with Axion BioSystems’ manage...
Credit: www.biorescue.org/Leibniz-IZW The BioRescue research project, a programme aiming at saving the northern white rhinoceros from extinction, exemplifies the challenges to overcome when conducting research and conservation in an international consortium in times of a global pandemic. COVID-19 hampered communication and travels, prevented or delayed crucial procedures, caused losses in revenues and by that may have lowered the chances of a survival of the northern white rhino. The consortium adjusted strategies, gained valuable knowledge during these challenging times and continued with it...